Trevi Therapeutics Inc. (TRVI)
NASDAQ: TRVI
· Real-Time Price · USD
8.46
-0.01 (-0.12%)
At close: Sep 25, 2025, 3:59 PM
8.48
0.22%
After-hours: Sep 25, 2025, 04:17 PM EDT
-0.12% (1D)
| Bid | 8.1 |
| Market Cap | 1.03B |
| Revenue (ttm) | 146K |
| Net Income (ttm) | -47.3M |
| EPS (ttm) | -0.42 |
| PE Ratio (ttm) | -20.14 |
| Forward PE | -16.76 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 8.89 |
| Volume | 1,275,177 |
| Avg. Volume (20D) | 2,220,622 |
| Open | 8.36 |
| Previous Close | 8.47 |
| Day's Range | 8.24 - 8.74 |
| 52-Week Range | 2.36 - 9.92 |
| Beta | 0.72 |
| Ex-Dividend Date | n/a |
About TRVI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TRVI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TRVI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-5.85%
Trevi Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
3 months ago
-2.92%
TRVI stock has given up its prior gain. Trevi Therapeutics shares were trading higher after the company announced positive topline results from its Phase 2b CORAL trial of Haduvio.
